Adipocytokine associations with insulin resistance in British south Asians

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Webb, D R ^a,b   Khunti, K ^a,b   Chatterjee, S ^c   Jarvis, J ^b   Davies, M J ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

^c BUCKINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SOUTH ASIA; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84879324691     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/561016     Document Type: Article

References (40)

1. Scherer P. E., Williams S., Fogliano M., Baldini G., Lodish H. F., A novel serum protein similar to C1q, produced exclusively in adipocytes. The Journal of Biological Chemistry 1995 270 45 26746 26749 2-s2.0-0028787490 10.1074/jbc.270.45.26746
2. Haluzik M., Parizkova J., Haluzik M. M., Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiology Research 2004 53 2 123 129 (Pubitemid 38525115)
3. Stefan N., Stumvoll M., Adiponectin: its role in metabolism and beyond. Hormone and Metabolic Research 2002 34 9 469 474 2-s2.0-0036750241 10.1055/s-2002-34785 (Pubitemid 35192231)
4. Li S., Shin H. J., Ding E. L., van Dam R. M., Adiponectin levels and risk of type 2 diabetes. A systematic review and meta-analysis. The Journal of the American Medical Association 2009 302 2 179 188 2-s2.0-67650169799 10.1001/jama.2009.976
5. Lindsay R. S., Funahashi T., Hanson R. L., Matsuzawa Y., Tanaka S., Tataranni P. A., Knowler W. C., Krakoff J., Adiponectin and development of type 2 diabetes in the Pima Indian population. The Lancet 2002 360 9326 57 58 2-s2.0-0037031088 10.1016/S0140-6736(02)09335-2 (Pubitemid 34756495)
6. Wannamethee S. G., Lowe G. D. O., Rumley A., Cherry L., Whincup P. H., Sattar N., Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007 30 5 1200 1205 2-s2.0-34247636175 10.2337/dc06-2416 (Pubitemid 46684648)
7. Bayés B., Granada M. L., Pastor M. C., Lauzurica R., Salinas I., Sanmartí A., Espinal A., Serra A., Navarro M., Bonal J., Romero R., Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. American Journal of Transplantation 2007 7 2 416 422 2-s2.0-33846224679 10.1111/j.1600-6143.2006.01646.x (Pubitemid 46096335)
8. Snehalatha C., Mukesh B., Simon M., Viswanathan V., Haffner S. M., Ramachandran A., Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003 26 12 3226 3229 2-s2.0-0344844389 10.2337/diacare.26.12.3226 (Pubitemid 37466879)
9. Snijder M. B., Heine R. J., Seidell J. C., Bouter L. M., Stehouwer C. D. A., Nijpels G., Funahashi T., Matsuzawa Y., Shimomura I., Dekker J. M., Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study. Diabetes Care 2006 29 11 2498 2503 2-s2.0-33845499740 10.2337/dc06-0952 (Pubitemid 44912259)
10. Koenig W., Khuseyinova N., Baumert J., Meisinger C., Löwel H., Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from Southern Germany. Journal of the American College of Cardiology 2006 48 7 1369 1377 2-s2.0-33748933358 10.1016/j.jacc.2006.06.053 (Pubitemid 44436825)
11. Spranger J., Kroke A., Möhlig M., Bergmann M. M., Ristow M., Boeing H., Pfeiffer A. F. H., Adiponectin and protection against type 2 diabetes mellitus. The Lancet 2003 361 9353 226 228 2-s2.0-0037452139 10.1016/S0140-6736(03)12255-6 (Pubitemid 36126226)
12. Knobler H., Benderly M., Boyko V., Behar S., Matas Z., Rubinstein A., Raz I., Wainstein J., Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose. European Journal of Endocrinology 2006 154 1 87 92 2-s2.0-32844469623 10.1530/eje.1.02054 (Pubitemid 43250741)
13. Choi K. M., Lee J., Lee K. W., Seo J. A., Oh J. H., Kim S. G., Kim N. H., Choi D. S., Baik S. H., Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clinical Endocrinology 2004 61 1 75 80 2-s2.0-3242722050 10.1111/j.1365-2265. 2004.02063.x (Pubitemid 38951648)
14. Daimon M., Oizumi T., Saitoh T., Kameda W., Hirata A., Yamaguchi H., Ohnuma H., Igarashi M., Tominaga M., Kato T., Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 2003 26 7 2015 2020 2-s2.0-1642467862 10.2337/diacare.26.7.2015 (Pubitemid 41184244)
15. Nakashima R., Kamei N., Yamane K., Nakanishi S., Nakashima A., Kohno N., Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. Journal of Clinical Endocrinology and Metabolism 2006 91 10 3873 3877 2-s2.0-33749540415 10.1210/jc.2006-1158 (Pubitemid 44536857)
16. Rabe K., Lehrke M., Parhofer K. G., Broedl U. C., Adipokines and insulin resistance. Molecular Medicine 2008 14 11-12 741 751 2-s2.0-55749105417 10.2119/2008-00058.Rabe
17. Sattar N., Wannamethee S. G., Forouhi N. G., Novel biochemical risk factors for type 2 diabetes-pathogenic insights or prediction possibilities? Diabetologia 2008 51 6 926 940 2-s2.0-43049099344 10.1007/s00125-008-0954-7
18. Whincup P. H., Gilg J. A., Papacosta O., Seymour C., Miller G. J., Alberti K. G. M. M., Cook D. G., Early evidence of ethnic differences in cardiovascular risk: cross-sectional comparison of British South Asian and white children. British Medical Journal 2002 324 7338 635 638 2-s2.0-0037117094 (Pubitemid 34234964)
19. Abate N., Chandalia M., Snell P. G., Grundy S. M., Adipose tissue metabolites and insulin resistance in non-diabetic Asian Indian men. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2750 2755 2-s2.0-2942685611 10.1210/jc.2003-031843 (Pubitemid 38766361)
20. Valsamakis G., Chetty R., McTernan P. G., Al-Daghri N. M., Barnett A. H., Kumar S., Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes, Obesity and Metabolism 2003 5 2 131 135 2-s2.0-0344091550 10.1046/j.1463-1326.2003.00254.x (Pubitemid 36372506)
21. Martin M., Palaniappan L. P., Kwan A. C., Reaven G. M., Reaven P. D., Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes Care 2008 31 4 798 801
22. Raji A., Gerhard-Herman M. D., Warren M., Silverman S. G., Raptopoulos V., Mantzoros C. S., Simonson D. C., Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. Journal of Clinical Endocrinology and Metabolism 2004 89 8 3965 3972 2-s2.0-4043102111 10.1210/jc.2004-0087 (Pubitemid 39071500)
23. Ferris W. F., Naran N. H., Crowther N. J., Rheeder P., van der Merwe L., Chetty N., The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Hormone and Metabolic Research 2005 37 11 695 701 2-s2.0-29144494451 10.1055/s-870580 (Pubitemid 41810493)
24. Wasim H., Al-Daghri N. M., Chetty R., McTernan P. G., Barnett A. H., Kumar S., Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovascular Diabetology 2006 5, article 10 2-s2.0-33745209898 10.1186/1475-2840-5-10 (Pubitemid 43905369)
25. Mente A., Razak F., Blankenberg S., Vuksan V., Davis A. D., Miller R., Teo K., Gerstein H., Sharma A. M., Yusuf S., Anand S. S., Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010 33 7 1629 1634 2-s2.0-77958187338 10.2337/dc09-1392
26. Luo M., Oza-Frank R., Mohan V., Narayan K. M., Gokulakrishnan K., Serum total adiponectin is associated with impaired glucose tolerance in Asian Indian females but not in males. Journal of Diabetes Science and Technology 2010 4 3 645 651 2-s2.0-78349303111
27. Bansal N., Anderson S. G., Vyas A., Gemmell I., Charlton-Menys V., Oldroyd J., Pemberton P., Durrington P. N., Clayton P. E., Cruickshank J. K., Adiponectin and lipid profiles compared with insulins in relation to early growth of British South Asian and European children: the manchester children's growth and vascular health study. Journal of Clinical Endocrinology and Metabolism 2011 96 8 2567 2574 2-s2.0-79961218885 10.1210/jc.2011-0046
28. Snehalatha C., Yamuna A., Ramachandran A., Plasma adiponectin does not correlate with insulin resistance and cardiometabolic variables in non-diabetic Asian Indian teenagers. Diabetes Care 2008 31 12 2374 2379 2-s2.0-64349114006 10.2337/dc08-1083
29. Gray L. J., Tringham J. R., Davies M. J., Webb D. R., Jarvis J., Skinner T. C., Farooqi A. M., Khunti K., Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study. Vascular Health and Risk Management 2010 6 837 842 2-s2.0-79951864518
30. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999
31. Khunti K., Taub N., Webb D. R., Srinivasan B., Stockman J., Griffin S. J., Simmons R., Davies M. J., Validity of self-assessed waist circumference in a multi-ethnic UK population. Diabetic Medicine 2012 29 3 404 409 10.1111/j.1464-5491.2011.03478.x
32. Zhu N., Pankow J. S., Ballantyne C. M., Couper D., Hoogeveen R. C., Pereira M., Duncan B. B., Schmidt M. I., High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. Journal of Clinical Endocrinology and Metabolism 2010 95 11 5097 5104 10.1210/jc.2010-0716
33. Mohan V., Deepa R., Pradeepa R., Vimaleswaran K. S., Mohan A., Velmurugan K., Radha V., Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology study (CURES-4). Metabolism 2005 54 4 476 481 2-s2.0-15744373886 10.1016/j.metabol.2004.10.016 (Pubitemid 40410448)
34. Retnakaran R., Qi Y., Connelly P. W., Sermer M., Hanley A. J., Zinman B., Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta-cell dysfunction and fasting glycaemia. Diabetologia 2010 53 2 268 276 2-s2.0-77949287201 10.1007/s00125-009-1600-8
35. Drapeau S., Doucet É., Rabasa-Lhoret R., Brochu M., Prud'homme D., Imbeault P., Improvement in insulin sensitivity by weight loss does not affect hyperinsulinemia-mediated reduction in total and high molecular weight adiponectin: a MONET study. Applied Physiology, Nutrition and Metabolism 2011 36 2 191 200 2-s2.0-79954574445 10.1139/h10-106
36. Cook J. R., Semple R. K., Hypoadiponectinemia-cause or consequence of human "insulin resistance"? Journal of Clinical Endocrinology and Metabolism 2010 95 4 1544 1554 2-s2.0-77951627717 10.1210/jc.2009-2286
37. Yudkin J. S., Yajnik C. S., Mohamed-Ali V., Bulmer K., High levels of circulating pro-inflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease. Diabetes Care 1999 22 2 363 364 2-s2.0-0032961728 10.2337/diacare.22.2.363 (Pubitemid 29056938)
38. Banerji M. A., Faridi N., Atluri R., Chaiken R. L., Lebovitz H. E., Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. Journal of Clinical Endocrinology and Metabolism 1999 84 1 137 144 2-s2.0-0032925461 10.1210/jc.84.1.137 (Pubitemid 29036692)
39. Hotamisligil G. S., Spiegelman B. M., Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994 43 11 1271 1278 2-s2.0-0028587742
40. Wang Y., Lam K. S. L., Yau M. H., Xu A., Post-translational modifications of adiponectin: mechanisms and functional implications. Biochemical Journal 2008 409 3 623 633 2-s2.0-38949125405 10.1042/BJ20071492 (Pubitemid 351214189)